, Ecole doctorale des Sciences de la Vie et de la Santé Année, 2010.
, Thèse n ° 1758 Thèse pour l ' obtention du DOCTORAT DE L ' UNIVERSITE BORDEAUX 2 Rôle des facteurs de transcription HIF ( Hypoxia Inducible Factor ) dans le maintien à long terme des cellule, pp.1-224, 2010.
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation, Mol. Cell. Biol, vol.12, issue.12, pp.5447-54, 1992. ,
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects, JNCI J. Natl. Cancer Inst, vol.93, issue.4, pp.266-276, 2001. ,
Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension, Am. J. Physiol, vol.271, issue.4, pp.1172-80, 1996. ,
Tissue oxygen distribution in head and neck cancer patients, Head Neck, vol.21, issue.2, pp.146-53, 1999. ,
Role of hypoxia-inducible factor (HIF)-1? versus HIF-2? in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: Implications for targeting the HIF pathway, Cancer Res, vol.66, issue.12, pp.6264-6270, 2006. ,
Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells, Genes Dev, vol.11, issue.1, pp.72-82, 1997. ,
HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation, J. Mol. Cell. Cardiol, vol.41, issue.1, pp.68-77, 2006. ,
Regulation of gene expression by hypoxia, Biochem. J, vol.414, issue.1, pp.19-29, 2008. ,
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension, Proc. Natl ,
, Acad. Sci, vol.92, issue.12, pp.5510-5514, 1995.
Inherent DNA-binding specificities of the HIF-1? and HIF-2? transcription factors in chromatin, EMBO Rep, vol.20, issue.1, 2019. ,
Inhibitory PAS Domain Protein (IPAS) Is a Hypoxia-inducible Splicing Variant of the Hypoxiainducible Factor-3? Locus, J. Biol. Chem, vol.277, issue.36, pp.32405-32408, 2002. ,
, Hypoxia-inducible factor-3? promotes angiogenic activity of pulmonary endothelial cells by repressing the expression of the VE-cadherin gene. -PubMed -NCBI
Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha, Gene Expr, vol.7, issue.3, pp.205-218, 1998. ,
A long hypoxia-inducible factor 3 isoform 2 is a transcription activator that regulates erythropoietin, Cell. Mol. Life Sci, 2019. ,
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation, Cell, vol.107, issue.1, pp.43-54, 2001. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00023372
Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation, Cell, vol.111, issue.5, pp.1085-1086, 2002. ,
, SUMOylation of hypoxia-inducible factor-1? reduces its transcriptional activity
URL : https://hal.archives-ouvertes.fr/hal-00319864
, Biochem. Biophys. Res. Commun, vol.360, issue.3, pp.646-652, 2007.
SUMO-Specific Protease 1 Is Essential for Stabilization of HIF1? during Hypoxia, Cell, vol.131, issue.3, pp.584-595, 2007. ,
HIF-1: master and commander of the hypoxic world, Biochem. Pharmacol, vol.68, issue.6, pp.971-980, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-00322376
Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo, J. Clin. Invest, vol.117, issue.4, pp.1068-1077, 2007. ,
Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis, Cardiovasc. Res, vol.39, issue.1, pp.8-33, 1998. ,
Mitochondria and reactive oxygen species in renal cancer, Biochimie, vol.89, issue.9, pp.1080-1088, 2007. ,
The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha, Cancer Res, vol.66, issue.7, pp.3688-98, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00321066
Hypoxia requires notch signaling to maintain the undifferentiated cell state, Dev. Cell, vol.9, issue.5, pp.617-645, 2005. ,
, , 2007.
Identification of the von Hippel-Lindau disease tumor suppressor gene, Science (80-. ), vol.260, issue.5112, pp.1317-1320, 1993. ,
VHL (von Hippel-Lindau), Bull. Cancer, vol.87, issue.41, pp.771-773, 2000. ,
The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13, Oncotarget, vol.8, issue.44, pp.75989-76002, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01620484
Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease, Hum. Mol. Genet, vol.10, issue.10, pp.1029-1067, 2001. ,
Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene, Oncogene, vol.10, issue.11, pp.2185-94, 1995. ,
Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease, Blood, vol.132, issue.5, pp.469-483, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01833917
Pre-mRNA splicing and human disease, Genes and Development, vol.17, issue.4, pp.419-437, 2003. ,
Gardie, and Réseau national maladie de VHL et prédispositions héréditaires au cancer du rein de l'Institut national du cancer (INCa), Bull. Cancer, vol.94, pp.170-179, 2007. ,
Molecular cloning and characterization of the von Hippel-Lindau-like protein, Mol. Cancer Res, vol.2, issue.1, pp.43-52, 2004. ,
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer, Nature Reviews Cancer, vol.8, issue.11, pp.865-873, 2008. ,
Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF, J. Biol. Chem, vol.282, issue.7, pp.4524-4556, 2007. ,
HIF prolylhydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia, EMBO J, vol.22, issue.16, pp.4082-90, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-00322761
Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor, J. Biol. Chem, vol.279, issue.37, pp.38458-38465, 2004. ,
Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor, Blood, vol.110, issue.10, pp.3610-3617, 2007. ,
Ironmediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutaratedependent oxygenase activity, Mol. Cell. Biol, vol.24, issue.3, pp.954-65, 2004. ,
Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels, J. Biol. Chem, vol.281, issue.33, pp.23482-23491, 2006. ,
Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins, Blood, vol.111, issue.6, pp.3229-3235, 2008. ,
Time-dependent inhibition of PHD2, Biosci. Rep, vol.37, issue.3, p.20170275, 2017. ,
Hypoxia signalling in cancer and approaches to enforce tumour regression, Nature, vol.441, issue.7092, pp.437-443, 2006. ,
The Peptidyl Prolyl cis/trans Isomerase FKBP38 Determines Hypoxia-Inducible Transcription Factor Prolyl-4-Hydroxylase PHD2 Protein Stability ,
, Cell. Biol, vol.27, issue.10, pp.3758-3768, 2007.
C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation, Cell, vol.107, issue.1, pp.43-54, 2001. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00023372
Cellular oxygen sensing: Importins and exportins are mediators of intracellular localisation of prolyl-4-hydroxylases PHD1 and PHD2, Biochem ,
, Biophys. Res. Commun, vol.387, issue.4, pp.705-716, 2009.
The role of hypoxia-inducible factors in tumorigenesis, Cell Death and Differentiation, vol.15, issue.4, pp.678-685, 2008. ,
The hallmarks of cancer, Cell, vol.100, issue.1, pp.81683-81692, 2000. ,
Studien Uber Kleinhirncysten. Bau, Pathogenese und Beziehungen zur Angiomatosis Retinae, Acta Pathol Microbiol Scand Suppl, vol.1, pp.1-128, 1926. ,
Von Hippel-Lindau disease: A genetic study, J. Med. Genet, vol.28, issue.7, pp.443-447, 1991. ,
An unappreciated role for RNA surveillance, Genome Biol, vol.5, issue.2, p.8, 2004. ,
Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease, Neurosurgical Review, vol.23, issue.1, pp.1-22, 2000. ,
, Medicine, vol.76, issue.6, pp.381-391, 1997.
Pancreatic involvement in von Hippel-Lindau disease, Gastroenterology, vol.119, issue.4, pp.1087-1095, 2000. ,
UMD (Universal mutation database): a generic software to build and analyze locus-specific databases, Hum. Mutat, vol.15, issue.1, pp.86-94, 2000. ,
Tumour suppression by the human von Hippel-Lindau gene product, Nat. Med, vol.1, issue.8, pp.822-826, 1995. ,
Redox stress is not essential for the pseudohypoxic phenotype of succinate dehydrogenase deficient cells, Biochim. Biophys. Acta -Bioenerg, vol.1757, issue.5-6, pp.567-572, 2006. ,
Structure of free fumarase C from Escherichia coli, Acta Crystallogr. Sect. D Biol. Crystallogr, vol.61, issue.10, pp.1395-1401, 2005. ,
Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer--Targeting the Warburg Effect in Cancer, Clin. Cancer Res, vol.19, issue.13, pp.3345-3352, 2013. ,
Prevalence of Somatic and Germline Mutations of Fumarate Hydratase in Uterine Leiomyomas from Young Patients, Histopathology, 2019. ,
A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-Deficient Renal Cell Carcinoma in 32 Patients, Am. J. Surg. Pathol, p.1, 2019. ,
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas, Hum. Mol. Genet, vol.23, issue.9, pp.2440-2446, 2014. ,
The role of PHD2 mutations in the pathogenesis of erythrocytosis, Hypoxia, vol.2, p.71, 2014. ,
Subunit structure of the erythropoietin receptor, J. Biol. Chem, vol.264, issue.18, pp.10507-10519, 1989. ,
Erythropoietin receptor characteristics on primary human erythroid cells, Blood, vol.77, issue.12, pp.2583-2590, 1991. ,
Immunohistochemical localization of erythropoietin and its receptor in the developing human brain ,
, Dev. Pathol, vol.2, issue.2, pp.148-58
Human, rat, and mouse kidney cells express functional erythropoietin receptors, Kidney Int, vol.55, issue.3, pp.808-820, 1999. ,
Signal Transduction in the Erythropoietin Receptor System, Exp. Cell Res, vol.253, issue.1, pp.143-156, 1999. ,
The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction, Trends Endocrinol. Metab, vol.10, issue.1, pp.18-23, 1999. ,
bcl-x prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation, J. Exp. Med, vol.189, issue.11, pp.1691-1699, 1999. ,
Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery, Cell, vol.91, issue.2, pp.80405-80410, 1997. ,
Signaling by type I and II cytokine receptors: ten years after, Curr. Opin. Immunol, vol.13, issue.3, pp.363-73, 2001. ,
Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways, Blood, vol.105, issue.12, pp.4604-4616, 2005. ,
, , pp.1871-1890
Purification of human erythropoietin, J. Biol. Chem, vol.252, issue.15, pp.5558-5564, 1977. ,
Cloning and expression of the human erythropoietin gene, Proc. Natl ,
, , vol.82, pp.7580-7584, 1985.
Isolation and characterization of genomic and cDNA clones of human erythropoietin, Nature, vol.313, issue.6005, pp.806-810, 1985. ,
Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor, Cell, vol.83, issue.1, pp.90234-90235, 1995. ,
A Gain-of-Function Mutation in <em>EPO</em> Gene Causes Familial Erythrocytosis, Blood, vol.130, pp.1653-1653, 2017. ,
The pleiotropic effects of erythropoietin in the central nervous system, J. Neuropathol. Exp. Neurol, vol.62, issue.3, pp.228-264, 2003. ,
Erythropoietin: Physiology and Pharmacology Update, Exp. Biol. Med, vol.228, issue.1, pp.1-14, 2003. ,
Erythropoietin, Compr. Physiol, vol.1, issue.4, pp.1759-1794, 2011. ,
Cardiovascular effects of erythropoietin. An update, Advances in Pharmacology, vol.60, issue.C, pp.257-285, 2010. ,
Neuroprotective effects of erythropoietin on Alzheimer's dementia model in rats ,
, Clin. Exp. Med, vol.26, issue.1, pp.23-29
Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid ?42 in mice, Brain Res, vol.1618, pp.159-67, 2015. ,
Une mutation unique de la protéine kinase JAK2 dans la polyglobulie de Vaquez et les syndromes myéloprolifératifs non-LMC ,
, Medecine/Sciences, vol.21, issue.6-7, pp.669-670, 2005.
The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels, Haematologica, vol.92, issue.12, pp.1607-1621, 2007. ,
Both proteasomes and lysosomes degrade the activated erythropoietin receptor, Blood, vol.105, issue.2, pp.600-608, 2005. ,
A Gain-of-Function Mutation in the HIF2A Gene in Familial Erythrocytosis, N. Engl. J. Med, vol.358, issue.2, pp.162-168, 2008. ,
Erythropoietin synthesis by tumour tissues in a patient with uterine myoma and erythrocytosis, Br. J. Haematol, vol.113, issue.1, pp.49-51, 2001. ,
Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis, Cancer Res, vol.74, issue.22, pp.6554-64, 2014. ,
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia, Nat. Genet, vol.32, issue.4, pp.614-635, 2002. ,
A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis, Proc. Natl. Acad. Sci. U. S. A, vol.103, issue.3, pp.654-663, 2006. ,
Disturbance in the HIF-1alpha pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene, Blood Cells. Mol. Dis, vol.40, issue.2, pp.160-165 ,
A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove, Blood, vol.110, issue.6, pp.2193-2196, 2007. ,
PHD2 Mutation and Congenital Erythrocytosis with Paraganglioma, N. Engl. J. Med, vol.359, issue.25, pp.2685-2692, 2008. ,
A gain-of-function mutation in the HIF2A gene in familial erythrocytosis, N. Engl. J. Med, vol.358, issue.2, pp.162-168, 2008. ,
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia, N. Engl. J. Med, vol.367, issue.10, pp.922-930, 2012. ,
Spliced segments at the 5' terminus of adenovirus 2 late mRNA, Proc. Natl. Acad. Sci. U. S. A, vol.74, issue.8, pp.3171-3175, 1977. ,
Alternative isoform regulation in human tissue transcriptomes, Nature, vol.456, issue.7221, pp.470-476, 2008. ,
A multicomponent complex is involved in the splicing of messenger RNA precursors, Cell, vol.42, issue.1, pp.80130-80136, 1985. ,
Alternative splicing: A pivotal step between eukaryotic transcription and translation, Nature Reviews Molecular Cell Biology, vol.14, issue.3, pp.153-165, 2013. ,
Hypoxia regulates alternative splicing of HIF and non-HIF target genes, Mol. Cancer Res, vol.12, issue.9, pp.1233-1276, 2014. ,
Splicing mutations in human genetic disorders: examples, detection, and confirmation, J. Appl. Genet, vol.59, issue.3, pp.253-268, 2018. ,
Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants, Methods in molecular biology, vol.653, pp.249-257, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02336373
, Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia. -PubMed -NCBI
Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia, Haematologica, vol.97, issue.1, pp.9-14, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-01401555
Update on mutations in the HIF: EPO pathway and their role in erythrocytosis, Blood Rev, vol.37, p.100590, 2019. ,
PHD2 Mutation and Congenital Erythrocytosis with Paraganglioma, N. Engl. J. Med, vol.359, issue.25, pp.2685-2692, 2008. ,
A genetic mechanism for Tibetan high-altitude adaptation, Nat. Genet, vol.46, issue.9, pp.951-956, 2014. ,
Genome-wide association between branch point properties and alternative splicing, PLoS Comput. Biol, vol.6, issue.11, pp.12-15, 2010. ,
Multipotent Caudal Neural Progenitors Derived from Human Pluripotent Stem Cells That Give Rise to Lineages of the Central and Peripheral Nervous System, Stem Cells, vol.33, issue.6, pp.1759-1770, 2015. ,
Exploring chemoselective S-to-N acyl transfer reactions in synthesis and chemical biology, Nat. Commun, vol.8, p.15655, 2017. ,
Basic analytical methods for identification of erythropoiesis-stimulating agents in doping control ,
, Chem. Rev, vol.85, issue.2, pp.99-114, 2016.
Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype, Kidney Int, vol.95, issue.2, pp.375-387, 2019. ,
Report on an anti-doping operation in Guadeloupe: High number of positive cases and inferences about doping habits, Drug Test. Anal, vol.9, issue.11-12, pp.1753-1761, 2017. ,
Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation, Cell, vol.168, issue.6, pp.1053-1064, 2017. ,
Non-AUG translation: A new start for protein synthesis in eukaryotes, Genes and Development, vol.31, issue.17, pp.1717-1731, 2017. ,
, TIA : attaque ischémique transitoire ; HFE : hémochromatose héréditaire ; VSI : variant de signification inconnu, Listes des variants publiées de PHD2, vol.3, 2018.
, Amorce de criblage du clonage EPO. Nom de l'amorce Séquences pCas2-A-F 5'-TCCAGGCTGACCCTGCTGACC-3' pCas2-B-R 5, Annexe, vol.9